NovaBridge Biosciences annual ebitda
2022
2023
2024
NovaBridge Biosciences EBITDA Growth & History (NBP)
NovaBridge Biosciences's calculated EBITDA was −$51.1M for fiscal 2024.
View full NovaBridge Biosciences company overviewNovaBridge Biosciences annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | −$51.1M | $20.4M | — |
| 2023 | 2023-12-31 | −$71.5M | −$18.6M | — |
| 2022 | 2022-12-31 | −$52.9M | — | — |
NovaBridge Biosciences quarterly ebitda
No reported data
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|
NovaBridge Biosciences ebitda trends
Across the available reported history, NovaBridge Biosciences's ebitda increased from −$71.5M to −$51.1M, a change of $20.4M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NovaBridge Biosciences filings at SEC.gov ↗